---

Comparison of efficacy of intrathecal hyperbaric ropivacaine and hyperbaric bupivacaine in terms of enhanced recovery after surgery (ERAS) for ACL reconstructions

Full Text PDF

---

Original Article

Author Details : Noopur Dasmit Singh, Payoja Narendra Khadpekar, Neha Amey Panse*, Varun Raj Dubey

Volume : 11, Issue : 2, Year : 2024

Article Page : 147-151

https://doi.org/10.18231/j.ijca.2024.031

Suggest article by email

Get Permission

Abstract

Background: Bupivacaine is the drug of choice in spinal anaesthesia (SA), while Ropivacaine with its comparatively shorter duration of motor block allows early mobilization post ACL reconstruction surgery which is a crucial factor in Early Recovery after Surgery.
Materials and Methods: In this randomized double-blind comparative study of a total of 60 patients irrespective of gender undergoing ACL reconstruction surgery were studied. After Administration of SA to group R (2.5ml of 0.75% Heavy Ropivacaine) & group B (2.5ml of 0.5% Bupivacaine) both were compared for their post-operative effects with Bromage score, Aldrete score & Visual Analogue Score.
Result: The time required for complete regression of motor blockade in group R (144.5+26.1 mins) < group> Conclusion: Hyperbaric Ropivacaine when compared to Bupivacaine promises better results in terms of early ambulation and intraoperative hemodynamic stability promoting ERAS in patients undergoing ACL reconstruction surgeries. Promoting ERAS policy will reduce the duration of hospital stay, thereby improving the cost-effectiveness of health services.

Keywords: Anterior cruciate ligament, Bupivacaine, Enhanced recovery after surgery, Ropivacaine.

How to cite : Singh N D, Khadpekar P N, Panse N A, Dubey V R, Comparison of efficacy of intrathecal hyperbaric ropivacaine and hyperbaric bupivacaine in terms of enhanced recovery after surgery (ERAS) for ACL reconstructions. Indian J Clin Anaesth 2024;11(2):147-151

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.